Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.

GREY:ALEAF - Post by User

Aleafia Health Inc > $22.7 Million raised at $0.83 per share = BuyTime @ $0.56 :)

<< Previous

Bullboard Posts

Next >>

Comment by ShakngMyHead00on Apr 19, 2021 6:26pm

119 Views

Post# 33026391

RE:RE:RE:$22.7 Million raised at $0.83 per share = BuyTime @ $0.56 :)

1hot-techwoman wrote:
ShakngMyHead00 wrote:

1hot-techwoman wrote:
Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering

Tuesday, March 9, 2021, 9:21 AM ET

Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, March 09, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health" or the "Company") is pleased to announce that it has closed its previously announced bought deal offering (the "Offering") for a total issuance of 27,390,000 units of the Company ("Units") at a price per Unit of $0.83 for gross proceeds of $22.7 million, which includes a partial exercise of the over-allotment option. The offering was led by Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc. and Mackie Research Capital Corp. (together, the "Underwriters").

Each Unit consists of one common share in the capital of the Company (a "Common Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of $1.05, for a period of 24 months following the closing of the Offering.

Steal of a deal at this level :)